Market Insights Health OTC Pharmaceuticals

Wound Care - Mexico

Mexico

In Mexico, the revenue in the Wound Care market market is projected to reach US$10.47m in 2024.
It is anticipated that the market will experience an annual growth rate of -0.15% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue in this market, amounting to US$1,052.00m in 2024.
In terms of per person revenues, in Mexico generates US$0.08 in 2024.
The demand for advanced wound care products in Mexico is growing due to the increasing prevalence of chronic wounds.

Key regions: Australia, Europe, Canada, United States, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Wound Care market in Mexico is experiencing steady growth due to several factors.

Customer preferences: Mexican consumers are increasingly prioritizing their health and well-being, which has led to a growing demand for wound care products. This trend is driven by a number of factors, including an aging population, rising awareness of the importance of wound care, and an increase in chronic diseases such as diabetes.

Trends in the market: One of the key trends in the Mexican wound care market is the growing adoption of advanced wound care products. These products, such as hydrogels, foam dressings, and negative pressure wound therapy, offer improved healing outcomes compared to traditional wound care methods. The demand for these products is driven by the desire for faster healing times, reduced pain, and improved quality of life for patients. Another trend in the market is the increasing focus on infection prevention. Infections are a common complication of wounds, and healthcare providers are placing greater emphasis on preventing and treating them. This has led to a growing demand for antimicrobial dressings and other products that help reduce the risk of infection.

Local special circumstances: Mexico has a large population, and the prevalence of chronic diseases such as diabetes is high. This has contributed to a significant demand for wound care products, as individuals with chronic conditions are more likely to develop wounds that require treatment. In addition, Mexico has a growing middle class with increasing disposable income, which has allowed more people to afford wound care products and services.

Underlying macroeconomic factors: Mexico's healthcare system is undergoing significant reforms, which are aimed at improving access to healthcare services and increasing the quality of care. These reforms have led to increased investment in healthcare infrastructure and the expansion of healthcare coverage. As a result, more people in Mexico are able to access wound care services, which has contributed to the growth of the market. Furthermore, Mexico has a strong manufacturing sector, which has helped to drive the production of wound care products. The country has a skilled workforce and a favorable business environment, which has attracted investment from multinational companies. This has led to the establishment of manufacturing facilities in Mexico, allowing for the production of high-quality wound care products at competitive prices. In conclusion, the Wound Care market in Mexico is experiencing steady growth due to factors such as increasing consumer preferences for advanced wound care products, a focus on infection prevention, a large population with a high prevalence of chronic diseases, healthcare reforms, and a strong manufacturing sector. These factors are expected to continue driving the growth of the market in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.